Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics

Abstract

Theranostic systems are receiving ever-increasing attention due to their potential therapeutic utility, imaging enhancement capability, and promise for advancing the field of personalized medicine, particularly as it relates to the diagnosis, staging, and treatment of cancer. In this Tutorial Review, we provide an introduction to the concepts of theranostic drug delivery effected via use of conjugates that are able to target cancer cells selectively, provide cytotoxic chemotherapeutics, and produce readily monitored imaging signals in vitro and in vivo. The underlying design concepts, requiring the synthesis of conjugates composed of imaging reporters, masked chemotherapeutic drugs, cleavable linkers, and cancer targeting ligands, are discussed. Particular emphasis is placed on highlighting the potential benefits of fluorogenic reaction-based targeted systems that are activated for both imaging and therapy by cellular entities, e.g., thiols, reactive oxygen species and enzymes, which are present at relatively elevated levels in tumour environments, physiological characteristics of cancer, e.g., hypoxia and acidic pH. Also discussed are systems activated by an external stimulus, such as light. The work summarized in this Tutorial Review will help define the role fluorogenic reaction-based, cancer-targeting theranostics may have in advancing drug discovery efforts, as well as improving our understanding of cellular uptake and drug release mechanisms.

Recent progress in biomedical applications of RGD‐based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review

“…In addition, it can offer several advantages such as better diagnosis, specific delivery as well as reducing side effects (Lee et al, 2018). In addition, it can offer several advantages such as better diagnosis, specific delivery as well as reducing side effects (Lee et al, 2018).…”

Towards NIR‐Active Hydroxybenzazole (HBX)‐Based ESIPT Motifs: A Recent Research Trend

“…In‐contrast, the fluorescent probes with absorption and emission in far‐red to NIR region are favorable for bioimaging because of deep tissue penetration, minimum photo damage to biological samples, minimum interference from background autofluorescence by biomolecules in the living systems. . Hence, NIR fluorophores have emerged as promising modalities in monitoring in‐vitro and in‐vivo levels of several biologically important species .…”

Peptide‐Driven Targeted Drug‐Delivery System Comprising Turn‐On Near‐Infrared Fluorescent Xanthene–Cyanine Reporter for Real‐Time Monitoring of Drug Release

“…TDD systems that are additionally equipped with a turn‐on fluorescent reporter that is sensitive to drug release open the way to real‐time monitoring of drug delivery in vitro and in vivo . The nonfluorescent reporter bound to the drug by means of a cleavable linker, which is predominantly degradable in the tumor, becomes fluorescent upon release of the drug, and thus, provides highly important information on drug distribution and drug‐release kinetics …”